Leukoplakia clinical trials at UCSD
1 studies in progress, 0 open to new patients

This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.